INGENUITY CREATES MILESTONES

OF INTELLIGENT MANUFACTURING

DFVision® 3D Electronic Laparoscope was awarded the "Top 10 Medical Devices List" in the 14th Health China Forum
2022-08-06 GMT+8 AM 07:00

On July 28, 2022, the 14th Health China Forum was held in Beijing. The Health China Forum, jointly organized by People's Daily Health Client and Health Times, is one of the earliest, most influential, highly valued and most authoritative conferences in China's medical and health sector with the theme of "Health China".

 

Based on the indicators of innovation, breakthrough and influence, this forum comprehensively sorted out the medical devices that have been marketed in China in 2021 and announced the "Top 10 Medical Devices List" on August 3. The DFVision® 3D Electronic Laparoscope, which was developed by MicroPort® MedBot®, was selected.

 

Launched by MicroPort® MedBot® in 2021, the DFVision® 3D Electronic Laparoscope is the first Chinese-developed 3D electronic laparoscope approved for marketing, and the first 3D electronic laparoscope brand to enter the special approval channel for innovative medical devices of the National Medical Products Administration. With the application of self-developed high-resolution imaging objective and electron microscope structure, DFVision® not only realizes full HD presentation of dual-channel images, but also significantly reduces the weight of the mirror body and optimizes operating experience. It fills the gap in 3D electronic laparoscope in China, helping Chinese laparoscopic surgery to match international level.

 

During surgery, the three-dimensional and longitudinal surgical field provided by DFVision® is important for precise freeing, suturing and knotting. This device may reduce operation time and errors; improve operation quality and efficiency, truly break through the limitations of traditional two-dimensional laparoscopic surgery and is widely used in clinical departments, such as general surgery, gynecology and urology.

 

Mr. Yu Liu, Executive Vice President and Chief Commercial Officer of MicroPort® MedBot®, said, "Being selected for the Health China Forum - Top 10 Medical Devices List is a recognition and a new starting point. In 2022, two other flagship products of MicroPort® MedBot®, the Toumai® Laparoscopic Surgery Robot and the Honghu Orthopedic Surgery Robot, will be launched one after another, leading the domestic market and empowering doctors. MicroPort® MedBot® will continue to pursue higher product performance thereafter, demonstrate the craftsmanship & excellence of domestic high-end medical devices, and 'Make Surgery Easier, Safer and Less Invasive'.”

For more information,
please click here.